| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AT-rich interaction domain 2 | 0.543 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
microRNA 375 | 0.476 | 0.769 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
microRNA 150 | 0.455 | 0.808 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
transcription factor binding to IGHM enhancer 3 | 0.542 | 0.654 | 0.98 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2015 | 2017 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 1996 | 2013 | ||||||||
|
CYLD lysine 63 deubiquitinase | 0.498 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0.900 | 10 | 2 | 1996 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.500 | None | 0.933 | 15 | 3 | 1996 | 2017 | ||||||||
|
MYB proto-oncogene, transcription factor | 0.490 | 0.692 | 0.82 |
|
disease | 0.400 | None | 0.963 | 54 | 0 | 2009 | 2019 | ||||||||
|
nuclear factor I B | 0.573 | 0.654 | 1.00 |
|
disease | 0.400 | None | 1.000 | 34 | 0 | 2009 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 1999 | 2019 | ||||||||
|
MYB proto-oncogene like 1 | 0.705 | 0.308 | 1.00 |
|
disease | 0.400 | None | 1.000 | 11 | 0 | 2013 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1996 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2004 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2000 | 2017 | ||||||||
|
SRY-box transcription factor 10 | 0.461 | 0.808 | 0.99 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2016 | 2019 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 2002 | 2017 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2017 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.440 | None | 1.000 | 5 | 2 | 2013 | 2018 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2000 | 2006 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2010 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.420 | None | 1.000 | 4 | 7 | 2013 | 2019 |